Regional differences in cardiac effects of pituitary adenylate cyclase-activating polypeptide-27 in the isolated dog heart
- 1 May 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 349 (2-3) , 269-276
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Multiple Human Receptors for Pituitary Adenylyl Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Are Expressed in a Tissue-Specific ManneraAnnals of the New York Academy of Sciences, 1996
- Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributionsEndocrinology, 1994
- Multiple receptors for PACAP and VIPTrends in Pharmacological Sciences, 1994
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Differential signal transduction by five splice variants of the PACAP receptorNature, 1993
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)Biochemical and Biophysical Research Communications, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Coexistence of β1 and β2-Adrenoceptors in the Rabbit HeartJournal of Cardiovascular Pharmacology, 1982
- A pharmacologic analysis of chronotropic and inotropic responses to direct electrical stimulation of the isolated, blood-perfused canine atrium.Japanese Heart Journal, 1980